Product image of Maxalt Lyo (Rizatriptan Benzoate) supplied by GNH India

Maxalt Lyo

Active Ingredient:
Rizatriptan Benzoate
Origin:
EU

Maxalt Lyo (Rizatriptan Benzoate)

Rizatriptan, the active ingredient in Maxalt Lyo, is a triptan presented as a oral lyophilisate tablet for oral use. It treats acute migraine attacks in adults, providing rapid relief of headache and associated symptoms.\n\nGNH India supplies Maxalt Lyo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Organon Belgium B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Rizatriptan is a selective serotonin 5‑HT1B/1D receptor agonist used in the acute treatment of migraine.\n\nMigraine without aura: reduces headache intensity and associated nausea.\nMigraine with aura: alleviates both headache and visual or sensory aura symptoms.\nAcute migraine attacks: provides rapid relief of pain, photophobia and phonophobia.

How It Works

  • Rizatriptan binds selectively to serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve terminals. Activation of these receptors causes vasoconstriction of intracranial arteries and inhibits release of pro‑inflammatory neuropeptides, thereby aborting the migraine cascade and reducing pain transmission.

Side Effects

  • Rizatriptan may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Taste disturbance or bitter taste\n- Nausea or abdominal discomfort\n- Dizziness or light‑headedness\n- Fatigue or drowsiness\n- Paresthesia (tingling)\n- Dry mouth\n\nSerious or Rare Side Effects:\n- Chest pain or tightness (possible coronary vasospasm)\n- Severe allergic reaction (anaphylaxis, rash, swelling)\n- Serotonin syndrome when combined with serotonergic agents\n- Hypertension or sudden increase in blood pressure\n- Cardiac arrhythmias\n- Ischemic stroke (very rare).

Precautions & Warnings

  • Before prescribing Rizatriptan, clinicians should evaluate cardiovascular risk and contraindications.\n\nAssess cardiovascular history: avoid in patients with coronary artery disease or uncontrolled hypertension.\nReview concomitant serotonergic drugs: monitor for serotonin syndrome.\nAvoid in patients with a history of hemiplegic or basilar migraine.\nCheck for drug interactions: especially MAO inhibitors and ergot derivatives.\nEducate patients on recognizing chest discomfort and seeking immediate care.\nStore at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

  • Rizatriptan can interact with several medication classes, requiring careful management.\n\nMajor Interactions (Avoid):\n- MAO inhibitors: increased risk of serotonin syndrome.\n- Other triptans or ergot alkaloids: additive vasoconstriction.\n- Strong CYP3A4 inhibitors (e.g., ketoconazole): elevated Rizatriptan levels.\n- SSRIs, SNRIs, or other serotonergic agents: heightened serotonin toxicity.\n- Monoamine oxidase inhibitors (within 14 days): risk of severe reactions.\n\nModerate Interactions (Monitor Closely):\n- Antihypertensive agents: possible additive blood pressure effects.\n- NSAIDs: may increase risk of gastrointestinal irritation.\n- Oral contraceptives: monitor for reduced efficacy.\n- Antihistamines: may enhance dizziness.\n- Alcohol: can exacerbate central nervous system side effects.

Frequently Asked Questions

Maxalt Lyo contains rizatriptan, a triptan class medication indicated for the acute treatment of migraine attacks in adults, with or without aura. It is taken at the onset of migraine symptoms to relieve headache, nausea, and sensitivity to light or sound.

Rizatriptan selectively stimulates serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This causes vasoconstriction of dilated intracranial arteries and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and reducing pain.

The specific dose of Maxalt Lyo is determined by the prescribing clinician based on the patient’s medical history and severity of migraine. Dosage instructions are provided on the prescription label and should be followed exactly as directed by a healthcare professional.

Safety data for rizatriptan in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their physician before using Maxalt Lyo.

To request Maxalt Lyo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other triptans, rizatriptan offers a rapid onset of action and is available as an oral lyophilisate that dissolves quickly in the mouth, which can be advantageous for patients experiencing nausea. It shares a similar efficacy profile with other triptans but may differ in side‑effect frequency and drug‑interaction potential.

Maxalt Lyo should be stored at ambient temperature below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Maxalt Lyo is an oral lyophilisate tablet that is placed on the tongue and allowed to dissolve completely without water. It should be taken as soon as migraine symptoms begin, and patients should avoid eating or drinking for a few minutes after administration to ensure optimal absorption.

Serious risks include chest pain or tightness indicating possible coronary vasospasm, severe allergic reactions such as anaphylaxis, and serotonin syndrome when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience any of these symptoms.

Maxalt Lyo is contraindicated in patients with known hypersensitivity to rizatriptan or any component of the formulation, those with uncontrolled hypertension, coronary artery disease, history of myocardial infarction, or patients who have experienced hemiplegic or basilar migraine. It should also be avoided in individuals taking MAO inhibitors or other triptans.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Rizatriptan Benzoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT